After decades of teaching and research at leading global institutions such as Harvard University and the Massachusetts ...

Google executive Sameer Samat sees the past year as one of curiosity about AI. This year, he's focused on its utility.

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

Google parent Alphabet Inc. on Monday became the fourth Big Tech powerhouse to be valued at $4 trillion, a once seemingly ...

Moxie Marlinspike—the pseudonym of an engineer who set a new standard for private messaging with the creation of the Signal ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...